Vaccine Experts Support Observational Studies

Two nationally recognized scientists with decades of experience advising U.S. vaccine policy have warned that excluding well‑designed observational studies from annual vaccine effectiveness assessments is a mistake. The experts—Dr. Jane Smith, a former senior advisor at the Centers for Disease Control and Prevention, and Dr. Robert Lee, a professor of epidemiology at the University of Washington—argue that observational data provide critical real‑world evidence that complements randomized controlled trials.

Observational studies, they explain, capture vaccine performance across diverse populations and varying conditions that controlled trials may not fully represent. By analyzing large health‑care databases and surveillance networks, these studies can identify effectiveness against emerging variants, assess durability of protection, and detect rare adverse events. The scientists emphasize that rigorous methodology—such as propensity score matching and sensitivity analyses—ensures that observational findings are reliable and can inform public health decisions in a timely manner.

The call for inclusion of observational evidence underscores a broader push for a more comprehensive evidence base in vaccine policy. Incorporating these studies could improve the accuracy of annual effectiveness estimates, guide resource allocation, and enhance public confidence in vaccination programs. The scientists’ stance highlights the need for policymakers to balance controlled trial data with real‑world observations to make fully informed decisions about vaccine use.